Reber joins 1315 Capital as partner

Philadelphia-based 1315 Capital, a healthcare-focused growth equity firm, has hired Matthew Q. Reber as a partner. Previously, Reber worked at HealthCare Royalty Partners where he most recently served as a managing director.


PHILADELPHIA, June 7, 2017 /PRNewswire/ — 1315 Capital, LLC, an expansion and growth equity firm that invests in commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, announced today the continued expansion of its senior investment team with the addition of Matthew Q. Reber as a Partner. Mr. Reber joins Founding Partners, Adele C. Oliva and Michael Koby, and brings deep healthcare investing experience across equity and debt transactions to 1315 Capital.

“Matt’s extensive transaction expertise and entrepreneurial spirit will help us continue to build 1315 Capital as a nationally recognized leader in healthcare expansion and growth equity,” said Oliva.

Mr. Reber joins 1315 Capital after spending nine years at HealthCare Royalty Partners, most recently as a Managing Director. He has fifteen years of growth stage investing experience with a focus on the specialty pharmaceutical and medical technology sectors. Mr. Reber has worked on over $1 billion in healthcare financings over the course of his career.

“I am excited to return to Philadelphia and have the opportunity to build on the tremendous success already achieved at 1315 Capital,” said Reber. “While we focus nationally, the richness of entrepreneurial activity and experienced management teams in the region provides an ideal backdrop to establish a leading growth and expansion stage healthcare investment firm.”

Mr. Reber holds a Bachelor of Science in Engineering degree, magna cum laude, from Princeton University, a Master of Business Administration degree with honors from The Wharton School of the University of Pennsylvania, and a Master of Biotechnology degree from the University of Pennsylvania.

About 1315 Capital
1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies. 1315 Capital leverages experienced investors and proven operating teams to work alongside portfolio company management to rapidly grow platform companies into high value businesses that positively impact patients, physicians, and the broader healthcare system. For more information, visit